Stratifying Multiple Sclerosis Susceptibility Risk: The Role of HLA-E*01 and Infectious Mononucleosis in a Population

Andrea Nova1, Davide Gentilini1,2, Giovanni Di Caprio1

  • 1Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.

PubMed
Abstract

Insights

Individuals with the HLA-E*01:01 gene variant and a history of infectious mononucleosis (IM) face a significantly higher risk of developing multiple sclerosis (MS). This finding highlights a potential genetic link between EBV infection and MS susceptibility.

Area of Science:

  • Immunogenetics
  • Neuroimmunology
  • Infectious Disease Epidemiology

Background:

  • Epstein-Barr Virus (EBV) infection and infectious mononucleosis (IM) are established risk factors for multiple sclerosis (MS).
  • The human leukocyte antigen (HLA) system plays a critical role in immune responses and MS susceptibility.
  • Previous in vitro studies suggested a protective role for HLA-E*01:03 against MS, contrasting with potential risks associated with HLA-E*01:01.

Purpose of the Study:

  • To investigate the association between the HLA-E*01:01 allele and MS risk in individuals with a history of IM.
  • To determine if HLA-E*01:01 interacts with IM history to modify MS risk.
  • To evaluate the role of HLA-E*01 alleles in the context of EBV infection and MS pathogenesis.

Main Methods:

  • Utilized a large cohort of 487,144 individuals from the UK Biobank.
  • Employed Cox proportional hazard models to assess the interaction between HLA-E*01:01 and IM history.
  • Adjusted for key covariates including demographics, smoking, body size, number of older siblings, and known MS-related HLA alleles like HLA-DRB1*15:01.

Main Results:

  • The HLA-E*01:01 allele alone was not significantly associated with IM or MS.
  • A significant interaction (p < 0.001) was found between HLA-E*01:01 and IM history regarding MS risk.
  • MS risk was substantially elevated in HLA-E*01:01 heterozygotes (HR=1.74) and homozygotes (HR=3.01) with a history of IM, compared to HLA-E*01:03 homozygotes.

Conclusions:

  • HLA-E*01:01 carriers with a history of IM exhibit significantly increased MS risk, independent of other HLA alleles.
  • This finding supports the hypothesis that HLA-E*01:01 may impair immune control over EBV infection, contributing to MS susceptibility.
  • Integrating HLA-E*01:01 status into risk models could improve personalized MS risk assessment for individuals with a history of IM.